Literature DB >> 16553535

Antidepressant side effects in children and adolescents.

C Thomas Gualtieri1, Lyn G Johnson.   

Abstract

The association between antidepressant treatment and suicidality in children and adolescents has been the subject of a great deal of recent discussion and controversy. Appropriate warnings have been attached to these drugs by governing bodies in the United Kingdom and the United States. However, the data upon which these deliberations have been based derive almost exclusively from clinical trials supported by the manufacturers of the respective drugs; data that are rigorous, in some respects, but which may not capture the clinical realities of antidepressant treatment in real-world settings. Data are presented from a neuropsychiatry clinic where 128 children and adolescents were treated with modern antidepressants over the past 14 months. Behavioral side effects, including suicidal ideation and self-injurious behavior, were not an uncommon accompaniment of antidepressant treatment. The problems, however, were mild and decidedly nonlethal and easily managed in the clinic setting. Ironically, 34 of 36 patients who had developed behavioral side effects to antidepressants were subsequently managed, without further incident, either on an alternative antidepressant or on lower doses of the offending agent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553535     DOI: 10.1089/cap.2006.16.147

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  4 in total

1.  Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD.

Authors:  Regina Bussing; Tanya K Murphy; Eric A Storch; Joseph P H McNamara; Adam M Reid; Cynthia W Garvan; Wayne K Goodman
Journal:  Psychiatry Res       Date:  2012-09-29       Impact factor: 3.222

2.  Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents.

Authors:  Shauna P Reinblatt; Susan DosReis; John T Walkup; Mark A Riddle
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-04       Impact factor: 2.576

3.  Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.

Authors:  Matthias W Riepe; Britta Walther; Catharina Vonend; Ambros J Beer
Journal:  BMC Psychiatry       Date:  2015-07-11       Impact factor: 3.630

4.  Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report.

Authors:  Trisha Chakrabarty; Shane J McInerney; Ivan J Torres; Benicio N Frey; Roumen V Milev; Daniel J Müller; Susan Rotzinger; Sidney H Kennedy; Raymond W Lam
Journal:  CNS Drugs       Date:  2021-03-08       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.